# Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

> **NCT00923845** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 25 (actual)

## Conditions studied

- Renal Cell Carcinoma
- Graft-Versus-Host Disease
- Engraftment Syndrome

## Interventions

- **DRUG:** Pentostatin
- **DRUG:** Sirolimus
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
- **PROCEDURE:** Th2 rapa cells
- **PROCEDURE:** Donor Lymphocyte Harvest
- **PROCEDURE:** Induction Therapy
- **PROCEDURE:** GVHD prophylaxis
- **PROCEDURE:** Donor Hematopoietic Stem Cell Harvest

## Key facts

- **NCT ID:** NCT00923845
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-01
- **Primary completion:** 2015-06-01
- **Final completion:** 2017-06-22
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00923845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00923845, "Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00923845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*